SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wiestler OD, Schiffer D, Coons SW, Prayson RA, Rosenblum MK. Ependymal tumors. In: KleihuesP, CaveneeWK, editors. Tumors of the nervous system. Pathology and genetics: World Health Organization international classification of tumours. Lyon: IARC Press, 2000: 7281.
  • 2
    Bouffet E, Perilongo G, Canete A, Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol. 1998; 30: 319329.
  • 3
    Hamilton RL, Pollack IF. The molecular biology of ependymomas. Brain Pathol. 1997; 7: 807822.
  • 4
    Smyth MD, Horn BN, Russo C, Berger MS. Intracranial ependymomas of childhood: current management strategies. Pediatr Neurosurg. 2000; 33: 138150.
  • 5
    Ernestus RI, Schröder R, Stützer H, Klug N. The clinical and prognostic relevance of grading in intracranial ependymomas. Br J Neurosurg. 1997; 11: 421428.
  • 6
    Figarella-Branger D, Civatte M, Bouvier-Labit C, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg. 2000; 93: 605613.
  • 7
    Foreman NK, Love S, Thorne R. Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg. 1996; 24: 119125.
  • 8
    Gerszten PC, Pollack IF, Martínez AJ, Lo KH, Janosky J, Albright AL. Intracranial ependymomas of childhood. Lack of correlation of histopathology and clinical outcome. Pathol Res Pract. 1996; 192: 515522.
  • 9
    Horn B, Heiderman R, Geyer R, et al. A multiinstitutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol. 1999; 21: 203211.
  • 10
    McLaughlin MP, Marcus RBJ, Buatti JM, et al. Ependymoma: results, prognostic factors and treatment recommendations. Int J Radiat Oncol Biol Phys. 1998; 40: 845850.
  • 11
    Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neurooncology Group. Med Pediatr Oncol. 1997; 29: 7985.
  • 12
    Robertson PL, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg. 1998; 88: 695703.
  • 13
    Schiffer D, Chio A, Cravioto H, Giordana MT, et al. Ependymoma: internal correlations among pathological signs: the anaplastic variant. Neurosurgery. 1991; 29: 206210.
  • 14
    Velen-Vincent MLC, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg. 2002; 97: 827835.
  • 15
    Merchant TE, Jenkins JJ, Burger PC, et al. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. Int J Radiat Oncol Biol Phys. 2002; 53: 5257.
  • 16
    McLendon RE, Enterline DS, Tien RD, Thorstad WL, Bruner JM. Tumors of central neuroepithelial origin. In: BignerDD, McLendonRE, BrunerJM, editors. Russel and Rubinstein's pathology of tumors of the nervous system, 6th edition, volume 1. London: Arnold, 1998; 387417.
  • 17
    Ironside JW, Moss TH, Louis DN, Lowe JS, Weller RO. Diagnostic pathology of nervous system tumors. London: Churchill Livingstone, 2002.
  • 18
    Ross GW, Rubinstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg. 1989; 70: 3136.
  • 19
    Hirose Y, Aldape K, Bollen A, et al. Chromosomal abnormalities subdivided ependymal tumors into clinically relevant groups. Am J Pathol. 2001; 159: 11371143.
  • 20
    Dyer S, Prebble E, Davison V, et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol. 2002; 161: 21332141.
  • 21
    Carter M, Nicholson J, Ross F, et al. Genetic abnormalities detected in ependymomas by comparative genome hybridization. Br J Cancer. 2002; 86: 929939.
  • 22
    Korshunov A, Neben K, Wrobel G, et al. Gene expression patterns in ependymomas correlate with tumor location, grade and patient age. Am J Pathol. 2003; 163: 17211727.
  • 23
    Paulino AC. Radiotherapeutic management of intracranial ependymoma. Pediatr Hematol Oncol. 2002; 19: 295308.
  • 24
    Souweidane MM, Bouffet E, Finlay J. The role of chemotherapy in newly diagnosed ependymoma in childhood. Pediatr Neurosurg. 1998; 28: 273278.
  • 25
    Timmermann B, Kortmann RD, Kuhl J, et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT88/89 and HIT 91. Int J Radiat Oncol Biol Phys. 2000; 46: 287295.
  • 26
    Chou PM, Barquin N, Gonzales Crussi F, Ridaura Sanz C, Tomita T, Reyes Mugica M. Ependymomas in children express the multidrug resistance gene: immuno-histochemical and molecular biology study. Pediatr Pathol Lab Med. 1996; 16: 551561.
  • 27
    Geddes JF, Vowle GH, Ashmore SM, Cockburn HA, Darling JL. Detection of multidrug resistance gene product (P-glycoprotein) expression in ependymomas. Neuropathol Appl Neurobiol. 1994; 20: 118121.
  • 28
    Korshunov A, Sycheva R, Timirgaz V, Golanov A. Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas. An analysis of 76 cases. J Neuro-Oncol. 1999; 45: 219227.